Exactech received FDA 510(k) clearance to market the Equinoxe® Stemless Shoulder, a bone- and canal-sparing implant for total shoulder arthroplasty. Limited launch is underway, with expanded release slated for 2H18.
The device is accompanied by a single instrument tray to support O.R. efficiency, and features a 3D porous structure and bone cage to enhance biologic fixation.
The Equinoxe line, first launched in 2004, includes components for primary, revision, reverse, fracture, resurfacing, etc.
Source: Exactech
Exactech received FDA 510(k) clearance to market the Equinoxe® Stemless Shoulder, a bone- and canal-sparing implant for total shoulder arthroplasty. Limited launch is underway, with expanded release slated for 2H18.
The device is accompanied by a single instrument tray to support O.R. efficiency, and features a 3D porous structure and bone...
Exactech received FDA 510(k) clearance to market the Equinoxe® Stemless Shoulder, a bone- and canal-sparing implant for total shoulder arthroplasty. Limited launch is underway, with expanded release slated for 2H18.
The device is accompanied by a single instrument tray to support O.R. efficiency, and features a 3D porous structure and bone cage to enhance biologic fixation.
The Equinoxe line, first launched in 2004, includes components for primary, revision, reverse, fracture, resurfacing, etc.
Source: Exactech
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.